Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Table of Contents | Next Article »
Hypertension. 1999;33:607-608

This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frohlich, E. D.
Right arrow Articles by Ré, R. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frohlich, E. D.
Right arrow Articles by Ré, R. N.

(Hypertension. 1999;33:607-608.)
© 1999 American Heart Association, Inc.

Editorial

Hypertension

The First Five Years

Edward D. Frohlich, MD, Editor-in-Chief; L. Gabriel Navar, PhD; Richard N. Ré, MD, Associate Editors

As we indicated in last month's editorial, 1999 marks the 20th Anniversary of Hypertension. The editors, desirous of celebrating this milestone, thought long and hard about how we might emphasize its importance for our readers without inordinately depriving our authors of valuable page space. To do this, we first elected to cite the important individuals who brought their influence to bear in establishing Hypertension as one of the American Heart Association's scientific publications. Last month we honored Dr Louis Tobian, who was the Chairman of the Council for High Blood Pressure Research, for bringing his forceful message loud and clear to the American Heart Association and its Scientific Publications Committee.

This month we are pleased to feature the first editor of the journal, Dr Harriet P. Dustan, who was also most important for her influence in creating our journal. As she indicates in her recollections in this month's issue, she accepted editorship for a five-year period perhaps out of forfeiture; but this was indeed a fortunate selection for the readers of the journal and the members of the Council. Assisted by Drs Suzanne Oparil and Henry Overbeck as Associate Editors, she was able to bring Hypertension from a journal published every other month (including the proceedings issue of the Fall scientific conference of the Council for High Blood Pressure Research) to a journal that would be published monthly (with the Council's Fall proceedings as a 13th issue) in the hands of the next editorial team, to be honored next month, Dr Edgar Haber and his associates in Boston.

What we also propose to do in this and in the four subsequent issues of Hypertension, is to honor those authors whose papers received the greatest impact by their frequency of reference in the literature in each five-year period of the journal. It may be of great interest for those individuals who have worked long and hard in hypertension research over these years to see the names and work of those investigators and what has happened in their research activities over the ensuing years. So, the editors are most pleased to honor the first Editor of Hypertension with her photograph on our cover together with her Associate Editors. After we honor each of the subsequent editors and those authors whose manuscripts published in their respective tenures having the greatest impact on the world of hypertension literature, we will then honor other individuals for their important impact in hypertension research. We shall hold this concept for a while and hope the readers will be pleased with the means that we have selected to celebrate our 20th anniversary.

The following are the top 25 papers published in Hypertension between 1979–1983 according to their frequency of reference in the literature (in alphabetical order). Please note: over these five years, Hypertension was published only six times annually.

  1. Adragna NC, Canessa ML, Solomon H, Slater E, Tosteson DC. Red cell lithium-sodium countertransport and sodium-potassium cotransport in patients with essential hypertension. Hypertension. 1982;4:795–804.
  2. Atlas SA, Case DB, Sealey JE, Laragh JH, McKinstry DN. Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natruiresis. Hypertension. 1979;1:274–280.
  3. Bertel O, Buhler FR, Kiowski W, Lutold BE. Decreased Beta-adrenoreceptor responsiveness as related to age, blood pressure, and plasma catecholamines in patients with essential hypertension. Hypertension. 1980;2:130–138.
  4. Bravo EL, Tarazi RC. Converting enzyme inhibition with an orally active compound in hypertensive man. Hypertension. 1979;1:39–46.
  5. Crofton JT, Share L, Shade RE, Lee-Kwon WJ, Manning M, Sawyer WH. The importance of vasopressin in the development and maintenance of DOC-salt hypertension in the rat. Hypertension. 1979;1:31–38.
  6. Crofton JT, Share L, Wang BC, Shade RE. Pressor responsiveness to vasopressin in the rat with DOC-salt hypertension. Hypertension. 1980;2:424–431.
  7. Devynck MA, Pernollett MG, Nunez AM, Meyer P. Analysis of calcium handling in erythrocyte membranes of genetically hypertensive rats. Hypertension. 1981;3:397–403.
  8. Erne P, Bolli P, Bertel O, Hulthen UL, Kiowski W, Muller FB, Buhler F. Factors influencing the hypotensive effects of calcium antagonists. Hypertension. 1983;5(Pt 2):II97–II102.
  9. Falkner B, Onesti G, Angelakos ET, Fernandes M, Langman C. Cardiovascular response to mental stress in normal adolescents with hypertensive parents: hemodynamics and mental stress in adolescents. Hypertension. 1979;1:23–30.
  10. Folkow B, Di Bona GF, Hjemdahl P, Toren PH, Wallin BG. Measurements of plasma norepinephrine concentrations in human primary hypertension: a word of caution on their applicability for assessing neurogenic contributions. Hypertension. 1983;5:399–403.
  11. Goldstein DS. Plasma norepinephrine in essential hypertension: a study of the studies. Hypertension. 1981;3:48–52.
  12. Goldstein DS. Plasma catecholamines and essential hypertension: an analytical review. Hypertension. 1983;5:86–99.
  13. Goldstein DS, McCarty R, Polinsky RJ, Kopin IJ. Relationship between plasma norepinephrine and sympathetic neural activity. Hypertension. 1983;5: 552–559.
  14. Hart MN, Heistad DD, Brody MJ. Effect of chronic hypertension and sympathetic denervation on wall/lumen ratio of cerebral vessels. Hypertension. 1980;2:419–423.
  15. Konishi M, Su C. Role of endothelium in dilator responses of spontaneously hypertensive rat arteries. Hypertension. 1983;5:881–886.
  16. Kuhn DM, Wolf WA, Lovenberg W. Review of the role of the central serotonergic neuronal system in blood pressure regulation. Hypertension. 1980;2:243–255.
  17. McCarron DA, Pingree PA, Rubin RJ, Gaucher SM, Molitch M, Krutzik S. Enhanced parathyroid function in essential hypertension: a homeostatic response to a urinary calcium leak. Hypertension. 1980;2:162–168.
  18. McCarron DA, Yung NN, Ugoretz BA, Krutzik S. Disturbances of calcium metabolism in the spontaneously hypertensive rat. Hypertension. 1981;3(Pt 2):1162–1167.
  19. Moore TJ, Crantz FR, Hollenberg NK, Koletsky RJ, Leboff MS, Swartz SL, Levine L, Podolsky S, Dluhy RG, William GH. Contribution of prostaglandins to the antihypertensive action of captopril in essential hypertension. Hypertension. 1981;3:168–173.
  20. Rapp JP. Dahl salt-susceptible and salt-resistant rats: a review. Hypertension. 1982;4:753–763.
  21. Sen S, Tarazi RC, Bumpus FM. Effect of converting enzyme inhibitor (SQ14,225) on myocardial hypertrophy in spontaneously hypertensive rats. Hypertension. 1980;2:169–176.
  22. Schaz K, Stock G, Simon W, Schlor KH, Unger T, Rockhold R, Ganten D. Enkephalin effects on blood pressure, heart rate, and baroreceptor reflex. Hypertension. 1980;2:395–407.
  23. Singer HA, Peach MJ. Calcium- and endothelial-mediated vascular smooth muscle relaxation in rabbit aorta. Hypertension. 1982;4(Pt 2):19–25.
  24. Swartz SL, Williams GH, Hollenberg NK, Moore TJ, Dluhy RG. Converting enzyme inhibition in essential hypertension: the hypotensive response does not reflect only reduced angiotensin II formation. Hypertension. 1979;1:106–111.
  25. Waeber B, Brunner HR, Brunner DB, Curtet AL, Turini GA, Gavras H. Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril. Hypertension. 1980;2:236–242.





This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frohlich, E. D.
Right arrow Articles by Ré, R. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frohlich, E. D.
Right arrow Articles by Ré, R. N.

Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.